Assessment of cognitive functions and psychiatric symptoms in hepatitis C patients receiving pegylated interferon alpha and ribavirin: A prospective cohort study

Shehab H Hassaan; Alaa M Darwish; Hossam Khalifa; Haidi Karam Alla Ramadan; Sahar M Hassany; Gellan K Ahmed; Ehab F Moustafa

doi:10.1177/0091217419858277

Assessment of cognitive functions and psychiatric symptoms in hepatitis C patients receiving pegylated interferon alpha and ribavirin: A prospective cohort study

Int J Psychiatry Med. 2019 Nov;54(6):424-440. doi: 10.1177/0091217419858277. Epub 2019 Jun 20.

Authors

Shehab H Hassaan¹, Alaa M Darwish¹, Hossam Khalifa¹, Haidi Karam Alla Ramadan², Sahar M Hassany², Gellan K Ahmed¹, Ehab F Moustafa²

Affiliations

¹ Department of Neurology and Psychiatry, Assiut University, Egypt.
² Tropical Medicine and Gastroenterlogy, Assiut University, Egypt.

PMID: 31219366
DOI: 10.1177/0091217419858277

No abstract available

Keywords: Hamilton Anxiety Rating Scale; Hamilton Depression Rating Scale; Memory Assessment Scales; Wechsler Adult Intelligence Scale-Revised; cognition; hepatitis C; interferon alpha.

MeSH terms

Adult
Antiviral Agents / therapeutic use*
Anxiety / psychology
Cognition / physiology*
Depression / psychology
Female
Hepatitis C / drug therapy
Hepatitis C / psychology*
Humans
Interferon-alpha / therapeutic use*
Male
Middle Aged
Neuropsychological Tests
Polyethylene Glycols / therapeutic use
Prospective Studies
Ribavirin / therapeutic use*

Substances

Antiviral Agents
Interferon-alpha
Polyethylene Glycols
Ribavirin